Werner S, Thorén M, Gustafsson J A, Brönnegård M
Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.
J Clin Endocrinol Metab. 1992 Oct;75(4):1005-9. doi: 10.1210/jcem.75.4.1400864.
A retrospective survey was accomplished on 420 consecutive patients who had undergone dexamethasone suppression tests between 1975-1988 due to suspected adrenal disorders. We found 7 patients in whom glucocorticoid resistance was apparent. They showed 4-6 abnormalities of the 7 investigations used: insensitivity to dexamethasone inhibition (n = 7), increased urinary cortisol (n = 3), glucocorticoid receptor (GR) thermolability (n = 4), decreased number of glucocorticoid receptors (n = 4), abnormal ligand affinity of GR (n = 4), abnormal basal GR mRNA expression (n = 4), and abnormal down-regulation of basal GR mRNA levels by dexamethasone (n = 1). The four patients with GR thermolability also showed increased basal GR mRNA levels. In the other patients the number of GR per cell was decreased without an up-regulation of GR mRNA. It is concluded that the syndromes of glucocorticoid resistance vary notably, clinically as well as biochemically; in patients evaluated for adrenocortical disorders the syndrome is apparently encountered in 1-2% of the patients.
对1975年至1988年间因疑似肾上腺疾病而接受地塞米松抑制试验的420例连续患者进行了回顾性调查。我们发现7例患者存在明显的糖皮质激素抵抗。他们在所用的7项检查中有4至6项异常:对地塞米松抑制不敏感(n = 7)、尿皮质醇增加(n = 3)、糖皮质激素受体(GR)热稳定性(n = 4)、糖皮质激素受体数量减少(n = 4)、GR的配体亲和力异常(n = 4)、基础GR mRNA表达异常(n = 4)以及地塞米松对基础GR mRNA水平的下调异常(n = 1)。4例GR热稳定性患者的基础GR mRNA水平也升高。在其他患者中,每个细胞的GR数量减少,而GR mRNA未上调。结论是,糖皮质激素抵抗综合征在临床和生化方面差异显著;在接受肾上腺皮质疾病评估的患者中,该综合征在1%至2%的患者中明显可见。